45 CFR § 180 compliance
A · 100
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
4,096
Insurances with rates
21
CPT / HCPCS codes
2,884
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| Q2043 | PROVENGE 50MIU INJ 250ML | $398,522 | $239,113 | $13,357 | $358,670 | 69 |
| C9293 | GLUCARPIDASE 1000U INJ | $196,289 | $117,774 | $13,357 | $176,660 | 45 |
| J2507 | PEGLOTICASE 8MG/ML INJ | $147,152 | $88,291 | $2,771 | $132,437 | 69 |
| C1820 | NEUROSTIM GEN RESTORE CHG | $115,700 | $69,420 | $0 | $104,130 | 32 |
| C1767 | NEUROSTIM GEN PULSE | $115,619 | $69,371 | $0 | $104,057 | 32 |
| C1889 | DISC CERVICAL REPL | $114,648 | $68,789 | $0 | $103,184 | 32 |
| J0638 | CANAKINUMAB 150MG/ML INJ | $104,531 | $62,719 | $113 | $94,078 | 138 |
| J2350 | OCRELIZUMAB 30MG/ML INJ 10ML | $103,637 | $62,182 | $57.33 | $93,273 | 69 |
| J9266 | PEGASPARGASE 3750U/5ML INJ | $94,436 | $56,662 | $5,540 | $84,992 | 69 |
| J3245 | TILDRAKIZUMAB-ASMN 100MG/ML INJ | $86,309 | $51,786 | $133 | $77,678 | 69 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140MG INJ | $83,276 | $49,965 | $112 | $74,948 | 69 |
| C1772 | IMP PAIN PUMP SYNCHROMED | $78,777 | $47,266 | $0 | $70,900 | 32 |
| 33262 | Removal and replacement of defibrillator pulse generator | $76,839 | $46,103 | $1,674 | $54,974 | 69 |
| 33264 | Removal and replacement of defibrillator pulse generator | $67,165 | $40,299 | $2,053 | $78,354 | 69 |
| J0896 | LUSPATERCEPT-AAMT 75MG INJ | $66,595 | $39,957 | $36.31 | $59,935 | 56 |
| C1768 | GFT VASCULAR TIER | $66,417 | $39,850 | $0 | $59,775 | 32 |
| J0598 | CINRYZE 500U INJ | $61,924 | $37,154 | $56.41 | $55,731 | 69 |
| J9043 | CABAZITAXEL 60MG/1.5ML INJ | $61,693 | $37,016 | $185 | $55,524 | 69 |
| J3357 | USTEKINUMAB SUBQ 45MG/0.5ML INJ | $57,402 | $34,441 | $180 | $51,662 | 69 |
| 93654 | Evaluation and insertion of catheters for recording, pacing, and attempted induction of abnormal hea | $54,989 | $32,993 | $362 | $51,214 | 69 |
| 93653 | Evaluation and insertion of catheters for creation of complete heart block | $54,828 | $32,897 | $1,153 | $51,214 | 69 |
| 93656 | Evaluation and insertion of catheters for recording, pacing, and treatment of abnormal heart rhythm | $53,716 | $32,229 | $764 | $51,214 | 69 |
| 33231 | Insert Defib Pulse Gen Only, Exist Mult Lead | $53,388 | $32,033 | $153 | $78,354 | 69 |
| C9069 | BELANTAMAB MAFODOTIN-BLMF 100MG INJ | $53,357 | $32,014 | $42.63 | $48,022 | 56 |
| J1640 | HEMIN 350MG INJ | $51,456 | $30,873 | $24.43 | $46,310 | 69 |
| 93581 | Perc Transcath Closure Congenital Vent Sept Defect | $51,166 | $30,700 | $1,293 | $38,329 | 69 |
| 33274 | Insertion or replacement of permanent leadless pacemaker into lower right chamber of heart via cathe | $51,129 | $30,677 | $2,080 | $38,329 | 69 |
| J9022 | ATEZOLIZUMAB 1200MG/20ML INJ | $50,542 | $30,325 | $78.18 | $45,488 | 69 |
| J9119 | CEMIPLIMAB-RWLC 50MG/ML INJ 7ML | $50,531 | $30,318 | $27.4 | $45,478 | 69 |
| J0222 | PATISIRAN NA 2MG/ML INJ 5ML | $47,572 | $28,543 | $97.68 | $42,815 | 69 |
| J9042 | BRENTUXIMAB 50MG INJ | $47,298 | $28,379 | $182 | $42,568 | 69 |
| 37242 | Vascular Embolization/Occlusion Arterial | $45,884 | $27,531 | $33.95 | $32,550 | 69 |
| J2323 | NATALIZUMAB 20MG/ML INJ 15ML | $45,505 | $27,303 | $22.39 | $40,954 | 69 |
| 37241 | Vascular Embolization/Occlusion Venous | $45,480 | $27,288 | $86.08 | $32,264 | 69 |
| 37243 | Occlusion of tumors or obstructed blood vessel with radiological supervision and interpretation, roa | $45,480 | $27,288 | $5,804 | $32,264 | 69 |
| 37244 | Vascular Embolization/Occlusion Hemorrhage | $45,335 | $27,201 | $339 | $32,160 | 69 |
| J9153 | DAUNORUBICIN-CYTARABINE 44MG/100MG INJ | $45,201 | $27,121 | $202 | $40,681 | 138 |
| J3380 | VEDOLIZUMAB 300MG INJ | $43,997 | $26,398 | $20.35 | $39,597 | 69 |
| 33240 | Insert Defib Pulse Gen Only, Exist Sgl Lead | $42,184 | $25,310 | $609 | $54,974 | 69 |
| J9144 | DARATUMUMAB-HYALURDASE-FIHJ 1800MG INJ 15ML | $41,641 | $24,985 | $43.85 | $37,477 | 56 |
| J1300 | ECULIZUMAB 10MG/ML INJ 30ML | $41,620 | $24,972 | $230 | $37,458 | 69 |
| J1303 | RAVULIZUMAB-CWVZ 10MG/ML INJ 30ML | $41,494 | $24,897 | $226 | $37,345 | 69 |
| J9228 | IPILIMUMAB 50MG/10ML INJ | $41,423 | $24,854 | $157 | $37,280 | 69 |
| J0180 | AGALSIDASE 35MG INJ | $40,714 | $24,428 | $189 | $36,643 | 69 |
| 33340 | LAA Closure W/ Implant | $39,927 | $23,956 | $52.67 | $28,324 | 69 |
| 37238 | Perc Placement IV Stent, 1st Vein | $39,493 | $23,696 | $46.01 | $28,016 | 69 |
| C9602 | Perc Transcath Plcmt Atherct Drug Stent, Sgl | $39,064 | $23,439 | $5,622 | $38,329 | 69 |
| 93580 | Perc Transcath Closure Congenital Intratrial Comm | $38,794 | $23,277 | $1,675 | $38,329 | 69 |
| C9600 | Perc Transcath Plcmt Drug Stent W/ Angio, Sgl | $37,779 | $22,667 | $5,611 | $34,001 | 69 |
| C9604 | Perc Translum Revasc Bypass Graft Drug Stnt, Sgl | $37,774 | $22,665 | $5,610 | $33,997 | 69 |
Showing top 50 of 4,096 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.